ArticleCureus2026
Successful Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Surgically Treated by the Fragmentation Technique: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 82-year-old woman was referred with a post-extraction bone sequestration to the Unit of Oral Surgery. She was treated for osteoporosis with bisphosphonate (BP; alendronic acid, 70 mg/week) for 15 years. According to the clinical signs, a stage 2 medication-related osteonecrosis of the jaw (MRONJ) was diagnosed. Preoperative treatment consisted of antibiotherapy combined with 0.12% chlorhexidine mouthwash. A specific surgical approach was used, sequestrectomy by fragmentation of the bone sequestrum. Antibiotherapy was continued until the bone was completely covered by the gum. The clinical and radiological controls at 24 months and 30 months, respectively, were satisfactory. Excision of bone sequestra measuring more than 10 mm by the fragmentation technique could minimize operative trauma and thereby recurrence. This hypothesis will have to be confirmed by clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.